Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. | Director | Common Stock | 163K | $247K | $1.51 | May 29, 2024 | Direct |
Taysha Gene Therapies, Inc. | Director | Stock Option (right to buy) | 98.4K | May 29, 2024 | Direct | ||
Tectonic Therapeutic, Inc. | Director | Stock Option (Right to Buy) | 11.8K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
TSHA | Taysha Gene Therapies, Inc. | May 29, 2024 | 2 | $0 | 4 | May 31, 2024 | Director |
TSHA | Taysha Gene Therapies, Inc. | Aug 16, 2023 | 1 | $100K | 4 | Aug 16, 2023 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
AVRO | AVROBIO, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
AVRO | AVROBIO, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 10, 2022 | Director |
TSHA | Taysha Gene Therapies, Inc. | Feb 2, 2022 | 1 | $23.3K | 4 | Feb 3, 2022 | Director |
TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
AVRO | AVROBIO, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |